# Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease

> **NCT04542967** · PHASE2 · COMPLETED · sponsor: **Hospital Central Militar** · enrollment: 150 (actual)

## Conditions studied

- Severe COVID-19 Disease

## Interventions

- **BIOLOGICAL:** Biological

## Key facts

- **NCT ID:** NCT04542967
- **Lead sponsor:** Hospital Central Militar
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-23
- **Primary completion:** 2020-09-02
- **Final completion:** 2020-09-30
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2021-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04542967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04542967, "Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04542967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*